http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111502-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_625dc50097e879ebb3d5bf815d3a3741
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
filingDate 2009-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815505e3842eff26b2ffd3731e285c4f
publicationDate 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011111502-A1
titleOfInvention Elimination of immune responses to viral vectors
abstract The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a viral vector antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or suppression of immune responses to viral vectors and in the manufacture of medicaments therefore.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011110964-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011002903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999346-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617748-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11193114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10662232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485768-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013039942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248171-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010330088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265394-B2
priorityDate 2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003104570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013095133-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011110964-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003152581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012009678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003129205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011002903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005202044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006211091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6759046-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003049723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010330088-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226716749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22311489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129533113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129062757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226716748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226716747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128557668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87100393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22794541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643460

Total number of triples: 91.